VIENNA, Austria—There may be potential differences in ischemic outcomes between the two most frequently used devices for left atrial appendage ... with the Amplatzer Amulet (Abbott) and 31.0% among ...

Abbott has reported late-breaking five-year positive data from a trial of its Amplatzer Amulet left atrial ... devices, the company’s Amplatzer Amulet and Boston Scientific's Watchman device.

More patients who received the Watchman 2.5 device compared with the Amulet occluder device for left atrial appendage occlusion experienced high-risk device-related thrombi (DRTs), according to a ...

Lipoprotein(a), or Lp(a), was successfully reduced in phase II trials of muvalaplin and zerlasiran. (JAMA) The possibility of a drug interaction between SGLT2 inhibitors and statins was not ...

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

Boston Scientific has proven itself to be a fierce competitor among three major cardiac device makers, with a track record of meaningful innovation and impressive operational chops. Even a ...

Ahmedabad: Keeping its cardiac focus in the medical device sector, Zydus MedTech, a wholly owned subsidiary of Indian pharma major Zydus Lifesciences, has obtained commercial rights to an aortic ...

Relevant risk for interaction seen with cardiac implantable electronic devices; no signs of cardiac damage seen during testing. HealthDay News — When applied to cardiac implantable electronic ...

The Watchman procedure involves implanting a small, parachute-shaped device in the left atrial appendage (LAA) to permanently close it off, preventing blood clots from forming and potentially ...

Researchers have developed a handheld device that could potentially replace stethoscopes as a tool for detecting certain types of heart disease. Researchers have developed a handheld device that ...

Elutia Inc. has announced the launch of a clinical study for EluPro™, the first FDA-cleared antibiotic-eluting bioenvelope designed for use with cardiac implantable electronic devices (CIEDs).